Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | LSS | P48449 | 2/20 | 0.37 |
| ▸ | GLB1 | P16278 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TLR4 | O00206 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.33 |
| ▸ | CNR1 | P21554 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17827044 | 1.00 | LMNA (0.44) | LMNAMAPK1HTTCYP1A2LSS | |
| SCHEMBL10053743 | 0.88 | CA1 (0.39) | LMNAMAPK1HTTMAPTGBA1 | |
| SCHEMBL21773610 | 0.88 | CA1 (0.39) | LMNAMAPK1HTTMAPTGBA1 | |
| SCHEMBL12279488 | 0.88 | CA1 (0.39) | LMNAMAPK1HTTMAPTGBA1 | |
| SCHEMBL12166491 | 0.84 | LMNA (0.44) | LMNAMAPK1HTTCYP1A2LSS | |
| SCHEMBL20203309 | 0.83 | CYP1A2 (0.46) | LMNAMAPK1HTTCYP1A2LSS | |
| SCHEMBL11903679 | 0.81 | CYP1A2 (0.48) | LMNAMAPK1HTTCYP1A2LSS | |
| SCHEMBL12166845 | 0.80 | CYP1A2 (0.43) | LMNAMAPK1HTTCYP1A2LSS | |
| SCHEMBL19197712 | 0.79 | CA1 (0.39) | CA1CA2CA4 | |
| SCHEMBL12166548 | 0.79 | CA1 (0.39) | CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151676-A1 | SILANE FUNCTIONAL STABILIZERS FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE | SOUTHWIRE COMPANY, LLC (US) | 2024-07-18 | — | — | WO | disclosed |
| US-20230360821-A1 | SILANE FUNCTIONAL STABILIZERS FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE | AMINDON INC. | 2023-11-09 | — | — | US | disclosed |
| US-20230360821-A1 | SILANE FUNCTIONAL STABILIZERS FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE | AMINDON INC. | 2023-11-09 | — | — | US | disclosed |
| US-11749422-B2 | Silane functional stabilizers for extending long-term electrical power cable performance | NOVINIUM, LLC (US) | 2023-09-05 | — | — | US | disclosed |
| US-11749422-B2 | Silane functional stabilizers for extending long-term electrical power cable performance | NOVINIUM, LLC (US) | 2023-09-05 | — | — | US | disclosed |
| US-20210017384-A1 | SILANE FUNCTIONAL STABILIZERS FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE | MADISON ELECTRIC PRODUCTS, LLC | 2021-01-21 | — | — | US | disclosed |
| US-20170342345-A1 | TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-30 | — | — | US | disclosed |
| US-20170327648-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2017-11-16 | — | — | US | disclosed |
| US-20170327647-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2017-11-16 | — | — | US | disclosed |
| US-20170283735-A1 | CONTROLLED RELEASE DUAL WALLED MICROCAPSULES | ENCAPSYS, LLC (US) | 2017-10-05 | — | — | US | disclosed |
| US-9012497-B2 | Cyclohexyl carbamate compounds as active anti-cellulite ingredients | SYMRISE AG (DE) | 2015-04-21 | — | — | US | disclosed |
| US-20150093350-A1 | ORGANOSILICONES | PROCTER & GAMBLE (US) | 2015-04-02 | — | — | US | disclosed |
| US-20140033448-A1 | ORGANOSILICONES | THE PROCTER & GAMBLE COMPANY (US) | 2014-02-06 | — | — | US | disclosed |
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | SYMRISE AG (DE) | 2013-06-20 | — | — | US | disclosed |
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | SYMRISE AG (DE) | 2013-06-20 | — | — | US | disclosed |
| US-20130137710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS | SYMRISE AG (DE) | 2013-05-30 | — | — | US | disclosed |
| US-20130137710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS | SYMRISE AG (DE) | 2013-05-30 | — | — | US | disclosed |
| US-20120052038-A1 | Organosilicones | THE PROCTER & GAMBLE COMPANY | 2012-03-01 | — | — | US | disclosed |
| EP-2389922-A1 | Cyclohexyl carbamate compounds as anti-ageing actives | Symrise AG (DE) | 2011-11-30 | — | — | EP | disclosed |
| EP-1829535-A2 | Tissue factor antagonists and methods of use thereof | Tanox, Inc. (US) | 2007-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150093350-A1 | ORGANOSILICONES | NISCH, XRCC6, RAD50 | LMNA 1605/4885MAPK1 3987/4885HTT 1207/4885 |
| US-20120052038-A1 | Organosilicones | NISCH, XRCC6, RAD50 | LMNA 1605/4885MAPK1 3987/4885HTT 1207/4885 |
| US-20170327648-A1 | SILICONE COMPOUNDS | SMCHD1, SMS, SGMS1 | LMNA 18/4885MAPK1 3468/4885HTT 2089/4885 |
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | CBR1, CYP2A13, CBR3 | LMNA 1211/4885MAPK1 3313/4885HTT 1529/4885 |
| US-20170283735-A1 | CONTROLLED RELEASE DUAL WALLED MICROCAPSULES | MYADM, MCHR2, MCHR1 | LMNA 1041/4885MAPK1 4578/4885HTT 88/4885 |
| US-20130137710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS | CBR1, NCOR2, CECR2 | LMNA 2360/4885MAPK1 4032/4885HTT 3466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.